Congress tradeHeld by the filer's dependent child per the disclosure. Disclosed 15 days after the transaction; reported as an official range, not an exact amount.
Loading…
Labcorp
LH · NYSE · Health Care Services
LH · NYSE · Health Care Services
Health Care Services company based in Burlington, North Carolina.
Last close, Oct 1, 2026
$304.60
Adjusted for splits and dividends
Last 12 months
+9.2%
S&P 500 +14.3% over the same dates
Market value
$24.7B
Last close × shares outstanding
Bets against the stock: 2.45M shares sold short (3.0% of shares outstanding), +16.4% vs the previous count, 3.3 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
5 sales
$3.17M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$14B
+7.2% vs the year before
Net income, fiscal 2025
$877M
As reported in the annual filing
Shares outstanding
81.1M
As of Aug 4, 2026
In fiscal 2025 the company spent $450M buying back its own shares and $241M on dividends. Cash actually paid, from its cash-flow statement.
Held by the filer's dependent child per the disclosure. Disclosed 15 days after the transaction; reported as an official range, not an exact amount.
Held by the filer's dependent child per the disclosure. Disclosed 33 days after the transaction; reported as an official range, not an exact amount.
Held by the filer's dependent child per the disclosure. Disclosed 34 days after the transaction; reported as an official range, not an exact amount.
Held by the filer's dependent child per the disclosure. Disclosed 35 days after the transaction; reported as an official range, not an exact amount.
Director sold ~$954K of Labcorp
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $279.06 on Oct 1, 2025 to $304.60 on Oct 1, 2026 (+9.2%). Disclosed trades in the last 12 months: 0 insider purchases, 21 insider sales (14 under pre-arranged plans), 7 Congress purchases, 4 Congress sales.
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Short sale volume: 48.8% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 57.9%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
Top officer leaving
“(the “Company”) of her decision to resign as Executive Vice President and President, Central Laboratories and International of the Company, effective September 4, 2026.”
5 insiders sold ~$2.31M in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.